Position in CERS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$19,571,734
+$11,331,734 QoQ
Shares Held
10,753,700
+168.8% QoQ
Ownership
5.37%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CERS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Soleus Capital Management, L.P. holds $529,137,690 across 15 Medical Devices names. CERS ranks #9 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
562,500 | $118,035,000 | |
| 2 | NVCR |
NovoCure Ltd
|
10,492,391 | $114,367,061 | |
| 3 | GMED |
Globus Medical Inc
|
729,467 | $62,850,876 | |
| 4 | BBNX |
Beta Bionics, Inc.
|
4,354,501 | $43,632,100 | |
| 5 | NPCE |
NeuroPace Inc
|
2,932,207 | $38,558,522 | |
| 6 | LIVN |
LivaNova PLC
|
582,500 | $37,023,700 | |
| 7 | INSP |
Inspire Medical Systems, Inc.
|
576,299 | $29,725,502 | |
| 8 | AXGN |
Axogen, Inc.
|
679,170 | $22,500,902 |
All Filings in CERS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,571,734 | 10,753,700 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $8,240,000 | 4,000,000 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||